A generalizable covalent car-t platform for solid tumors enabled by oncolytic adenovirus-delivered artificial antigens
BackgroundChimeric antigen receptor (CAR) T-cell therapy has shown limited efficacy against solid tumors due to antigen heterogeneity and scarcity of tumor-specific targets.MethodsTo address those challenges, we report a covalent CAR-T strategy that ac…